NCT01714297

Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)

A Prospective Randomized, Double Blind Study to Evaluate Safety and Effect With Pre Versus Postoperative Start of Thromboprophylaxis With Dalteparin

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Vestre Viken Hospital Trust · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine if there are differences in clinical events, i.e bleeding with associated morbidity, if thromboprophylaxis with LMWH (Low Molecular Weight Heparin) is initiated before or after surgery.

Conditions

• Arthritis of the Hip
• Transfusion Related Complications
• Infection
• Wound Discharge

Interventions

Type	Name	Description
DRUG	dalteparin 5000 IU s.c.	All patients receive injections with either 5000IU dalteparin or saline in the same volume the evening before surgery. All patients receive 5000IU dalteparin 6 hours after surgery and every day from day 2 until day 35.

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-06-01
• Completion: 2009-04-01
• First posted: 2012-10-25
• Last updated: 2012-12-10

Locations

1 site across 1 country: Norway